Health Care & Life Sciences » Biotechnology | Helius Medical Technologies Inc.

Helius Medical Technologies Inc. | Mutual Funds

Mutual Funds that own Helius Medical Technologies Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Total Stock Market Index Fund
409,633
1.75%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
341,815
1.46%
0
0.01%
07/31/2018
iShares Russell 2000 ETF
340,971
1.46%
-183
0.01%
09/06/2018
iShares Russell 2000 Growth ETF
160,710
0.69%
0
0.01%
09/06/2018
GBC Canadian Growth Fund
141,130
0.6%
-29,970
0.5%
12/31/2017
Fidelity Spartan Extended Market Index Fund
54,233
0.23%
15,425
0%
07/31/2018
iShares Micro Cap ETF
39,644
0.17%
0
0.04%
09/06/2018
Schwab Small Cap Index Fund
30,500
0.13%
30,500
0.01%
06/30/2018
Vanguard Institutional Total Stock Market Index Fund
28,966
0.12%
0
0%
07/31/2018
28,826
0.12%
0
0.01%
07/31/2018

About Helius Medical Technologies

View Profile
Address
642 Newtown Yardley Road
Newtown Pennsylvania 18940
United States
Employees -
Website http://www.heliusmedical.com
Updated 07/08/2019
Helius Medical Technologies, Inc. is a medical technology company, which engages in the development of products for the treatment of neurological symptoms caused by disease and trauma. It focuses on licensing and acquiring platform technologies that amplify the brain's ability to heal itself. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.